These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 14576602

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus.
    Edwards L, Ferenczy A, Eron L, Baker D, Owens ML, Fox TL, Hougham AJ, Schmitt KA.
    Arch Dermatol; 1998 Jan; 134(1):25-30. PubMed ID: 9449906
    [Abstract] [Full Text] [Related]

  • 3. The cost effectiveness of treatment of genital warts with podophyllotoxin.
    Mohanty KC.
    Int J STD AIDS; 1994 Jan; 5(4):253-6. PubMed ID: 7948154
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The treatment of anogenital warts at home.
    Pleavin M.
    Nurs Times; 1994 Jan; 97(6):37-8. PubMed ID: 11954248
    [No Abstract] [Full Text] [Related]

  • 6. Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT.
    Gilson R, Nugent D, Bennett K, Doré CJ, Murray ML, Meadows J, Haddow LJ, Lacey C, Sandmann F, Jit M, Soldan K, Tetlow M, Caverly E, Nathan M, Copas AJ.
    Health Technol Assess; 2020 Sep; 24(47):1-86. PubMed ID: 32975189
    [Abstract] [Full Text] [Related]

  • 7. Health economic evaluation of topical treatments for external anogenital warts.
    Agbeci H, Rollot O, Derancourt C, Baglione Q, Benard A, Bertolotti A.
    Ann Dermatol Venereol; 2024 Sep; 151(3):103288. PubMed ID: 39002407
    [Abstract] [Full Text] [Related]

  • 8. Imiquimod for anogenital warts in non-immunocompromised adults.
    Grillo-Ardila CF, Angel-Müller E, Salazar-Díaz LC, Gaitán HG, Ruiz-Parra AI, Lethaby A.
    Cochrane Database Syst Rev; 2014 Nov 01; 2014(11):CD010389. PubMed ID: 25362229
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of anogenital warts in children with topical 0.05% podofilox gel and 5% imiquimod cream.
    Moresi JM, Herbert CR, Cohen BA.
    Pediatr Dermatol; 2001 Nov 01; 18(5):448-50; discussion 452. PubMed ID: 11737696
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prognostic factors for the response to treatment in males with genital warts.
    Stefanaki C, Hadjivassiliou M, Katzouranis I, Bethimoutis G, Nicolaidou E, Anyfantakis V, Lagogianni E, Caroni C, Panagiotopoulos A, Antoniou C, Katsambas A.
    J Eur Acad Dermatol Venereol; 2009 Oct 01; 23(10):1156-60. PubMed ID: 19453776
    [Abstract] [Full Text] [Related]

  • 14. A short, 8-week course of imiquimod 5% cream versus podophyllotoxin in the treatment of anogenital warts: A retrospective comparative cohort study.
    Nicolaidou E, Kanelleas A, Nikolakopoulos S, Bezrodnii G, Nearchou E, Gerodimou M, Papadopoulou-Skordou E, Paparizos V, Rigopoulos D.
    Indian J Dermatol Venereol Leprol; 2021 Oct 01; 87(5):666-670. PubMed ID: 31650979
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Evaluation of imiquimod for the therapy of external genital and anal warts in comparison with destructive therapies.
    Schöfer H.
    Br J Dermatol; 2007 Dec 01; 157 Suppl 2():52-5. PubMed ID: 18067633
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Extensive condyloma acuminata treated with imiquimod 5% cream: a case report.
    Cox JT.
    Clin Exp Dermatol; 2003 Nov 01; 28 Suppl 1():51-4. PubMed ID: 14616817
    [Abstract] [Full Text] [Related]

  • 19. Imiquimod 5% cream for external genital or perianal warts in human immunodeficiency virus-positive patients treated with highly active antiretroviral therapy: an open-label, noncomparative study.
    Saiag P, Bauhofer A, Bouscarat F, Aquilina C, Ortonne JP, Dupin N, Mougin C.
    Br J Dermatol; 2009 Oct 01; 161(4):904-9. PubMed ID: 19466962
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.